Expression of the Gm1-Species, [NeuN]-GM1, in a Case of Human Glioma

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neurochemical Research

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1022570222876PMID 9972875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The presence of foetal ganglioside antigens 3′-IsoLM1 and 3′6′-IsoLD1 in both glioma tissue and surrounding areas from human brain

  2007cited by this paper
• Gangliosides in children with autism

  1995cited by this paper
• Effect of a new de-N-acetyl-lysoglycosphingolipid on some tumour models.

  1995cited by this paper
• Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors.

  1994cited by this paper
• GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction.

  1994cited by this paper
• Antiplatelet effects of a new de-N-acetyl-lyso-glycosphingolipid.

  1993cited by this paper
• Histological Typing of Tumours of the Central Nervous System

  1993cited by this paper
• A novel ganglioside with a free amino group in bovine brain.

  1993influential reference
• Murine Neuroblastoma Cells Express Ganglioside Binding Sites on Their Cell Surface

  1990cited by this paper
• Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

  1989cited by this paper
• Sialyllactotetraosylceramide, a Ganglioside Marker for Human Malignant Gliomas

  1988cited by this paper
• A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.

  1988cited by this paper
• Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line

  1986cited by this paper
• Potential ganglioside antigens associated with human gliomas.

  1986cited by this paper
• Trisialosyllactosylceramide (GT3) is a ganglioside of human lung

  1986cited by this paper
• Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin

  1983cited by this paper
• Histological Typing of tumours of the Central Nervous System

  1981cited by this paper
• Separation of gangliosides on a new type of anion-exchange resin.

  1980cited by this paper
• A procedure for the quantitative isolation of brain gangliosides.

  1980cited by this paper

• O-acetylated Gangliosides as Targets for Cancer Immunotherapy

  2020cites this paper
• Preparation of Cholera Toxin Subunit B Functionalized Nanoparticles for Targeted Therapy of Glioblastoma.

  2020cites this paper
• Cholera Toxin Subunit B Enabled Multifunctional Glioma‐Targeted Drug Delivery

  2017cites this paper
• Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer

  2017cites this paper
• Antigen-receptor gene-modified T cells for treatment of glioma.

  2012cites this paper
• Chip‐nanoelectrospray quadrupole time‐of‐flight tandem mass spectrometry of meningioma gangliosides: A preliminary study

  2012cites this paper
• Reprint of: chip-based nanoelectrospray mass spectrometry of brain gangliosides.

  2011cites this paper
• Chip-based nanoelectrospray mass spectrometry of brain gangliosides.

  2011cites this paper
• Immunotherapeutic approaches for glioma.

  2009cites this paper
• 1.03 – Glycosphingolipid Structures

  2007cites this paper
• Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR

  2007cites this paper
• Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization.

  2007cites this paper
• Microfluidic front-end technologies for protein electrospray mass spectrometry

  2006cites this paper
• Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

  2005cites this paper
• Role of Cytokines in the Regulation of Glioma Tumour Growth and Angiogenesis

  2005cites this paper
• Primary Malignant Brain Tumors

  2004cites this paper
• Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.

  2004cites this paper
• Justification of glioma biology beyond a cellular basis of interpretation.

  2003cites this paper
• NO, Immunosuppression and Tumor Immmunotherapy

  2002cites this paper
• Immune defects observed in patients with primary malignant brain tumors.

  1999cites this paper